Skip to main content

CarnoSyn® Brands Partners With Barentz for Exclusive Brazilian Distribution of CarnoSyn® Beta-Alanine

Written by Customer Service on . Posted in Public Companies.

CARLSBAD, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) — CarnoSyn® Brands and parent company Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), today announced its expansion in Brazil with Barentz, creating an exclusive distribution channel for CarnoSyn® beta-alanine throughout the entire Brazilian dietary supplements’ market. The new agreement strengthens brand expansion and distribution of a top selling ingredient in sports nutrition—CarnoSyn® beta-alanine—the only scientifically proven and globally patented beta-alanine.

“This new partnership illustrates our confidence in the Brazilian market and Barentz, who will provide an opportunity for more companies and brands to have access to CarnoSyn®, the safest and most studied beta-alanine available in the world,” shared Aaron Starr, Vice President, CarnoSyn® Brands. “We are confident that their experience and expertise will help grow and promote CarnoSyn® Brands in this region. Barentz has worked tirelessly to establish awareness for sports nutrition brands and life science ingredients in Brazil and South America for decades, with a proven track record of success. We look forward to a mutually beneficial business relationship.”

A leading distributor specializing in the life sciences market, Barentz in South America offers high-tech ingredients in various market sectors including dietary supplements, pharmaceuticals, personal care, foods, beverages, and animal nutrition. CarnoSyn® beta-alanine represents the latest innovative ingredient added to their specialty ingredient portfolio for distribution.

Moses Benzaquen, President Director of Barentz in Brazil, emphasized CarnoSyn®‘s exceptional quality, representing the pinnacle of muscle health supplements, “As leaders in the distribution market, we consistently pursue the finest global options, and CarnoSyn® distinguishes itself with proprietary clinical studies, ensuring both efficacy and quality. With the sports nutrition market booming in Brazil, beta-alanine not only addresses athletes’ needs but also resonates with consumers pursuing healthier lifestyles. We are confident in the success of our partnership with CarnoSyn® Brands.”

About Barentz
Barentz is a leading global Life Science ingredients distributor. The company sources branded specialty ingredients from leading manufacturers worldwide. Their team of ingredient experts provide value-added technical support which includes pre-mixing, blending, ingredients formulations and ingredient testing from state-of-the-art customized formulation centers and application laboratories in EMEA, Americas, and Asia-Pacific. Established in 1953, Barentz has operations in more than 70 countries with a strong presence in Europe and North America and a rapidly growing network in South America and Asia-Pacific. In 2018, Barentz, a world leader in products for the Life Science market, arrived in Brazil through a joint venture with Tovani Benzaquen. The company serves more than 2,000 customers throughout the entire Brazilian territory and surrounding countries. Tovani Benzaquen officially became Barentz from 2024 onward, expanding its portfolio to over 3,000 molecules while ensuring the quality of local service. With a turnover of € 2.5 billion, Barentz now employs around 2,600 people worldwide and serves over 25,000 customers. For more information, visit: www.barentz.com.

About CarnoSyn® Brands:
CarnoSyn® Brands feature two clinically studied, patented ingredients available exclusively from Natural Alternatives International, Inc.: CarnoSyn® instant release beta-alanine powder and SR CarnoSyn® sustained release beta-alanine tablets. In 2019, CarnoSyn® beta-alanine successfully obtained NDI status from the FDA and received Self-Affirmed GRAS (Generally Recognized as Safe) status. SR CarnoSyn®, an advanced delivery form of CarnoSyn®, received GRAS affirmation in 2017. The GRAS affirmation allows NAI to broaden their product offerings within the food and beverage industries, including medical and other fortified food products. For more information about CarnoSyn® in sports nutrition, please visit: www.carnosyn.com. For information on SR CarnoSyn® in healthy aging and wellness, visit www.srcarnosyn.com.

About NAI:
NAI, headquartered in Carlsbad, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. NAI’s comprehensive partnership approach offers a wide range of innovative nutritional products and services to clients including scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review, and international product registration assistance. For more information about NAI, please visit www.nai-online.com.

Contact:
Renee Michaelson
Director of Global Marketing
NAI/CarnoSyn® Brands
(760) 736-7700
info@nai-online.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.